290 related articles for article (PubMed ID: 32789442)
1. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma.
Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Jiang Y; Ye J
Am J Clin Pathol; 2020 Nov; 154(6):848-858. PubMed ID: 32789442
[TBL] [Abstract][Full Text] [Related]
2. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
3. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
5. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
[TBL] [Abstract][Full Text] [Related]
6. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
[TBL] [Abstract][Full Text] [Related]
7. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
8. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
[TBL] [Abstract][Full Text] [Related]
9. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
10. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
11. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
12. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
13. Number of tumor foci predicts prognosis in papillary thyroid cancer.
Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS
BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041
[TBL] [Abstract][Full Text] [Related]
14. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
15. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
17. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
Song RY; Kim HS; Kang KH
World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
[TBL] [Abstract][Full Text] [Related]
18. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma.
Yan Y; Wang Y; Liu N; Duan Y; Chen X; Ye B; Yang R; Zhang W; Wang X
Eur J Surg Oncol; 2021 Jul; 47(7):1727-1733. PubMed ID: 33632590
[TBL] [Abstract][Full Text] [Related]
20. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
